Pamaqueside
Pamaqueside (CP148623) is a cholesterol absorption inhibitor and a potent binder of the SARS-CoV-2 receptor-binding domain (RBD), which may inhibit viral cellular entry. Pamaqueside can be utilized in metabolic and antiviral research[1].
Product Specifications
CAS Number
150332-35-7
Product Name Alternative
CP148623
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pamaqueside.html
Smiles
C[C@@]12[C@]3([H])[C@@](C[C@@]1([H])[C@@]4([H])[C@]([C@@]5([C@@](C[C@H](CC5)O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O[C@@H]7O[C@@H]([C@H]([C@@H]([C@H]7O)O)O)CO)CO)([H])CC4)C)([H])C(C2)=O)([H])O[C@]8(CC[C@H](CO8)C)[C@H]3C
Molecular Formula
C39H62O14
Molecular Weight
754.90
References & Citations
[1]Behloul N, et al. In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain. Eur J Pharmacol. 2021 Jan 5;890:173701.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A1168sec-02 100 µL
Nuclear Receptor NR4A1 (Phospho Ser351) Antibody
Sign In for Pricing
View Details